Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Serina Therapeutics (SER) Interest Expenses (2021 - 2025)

Serina Therapeutics' Interest Expenses history spans 5 years, with the latest figure at $198000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 1064.71% to $198000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $213000.0, a 59.51% decrease, with the full-year FY2025 number at $213000.0, down 59.51% from a year prior.
  • Interest Expenses hit $198000.0 in Q4 2025 for Serina Therapeutics, up from $6000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for SER hit a ceiling of $978000.0 in Q4 2022 and a floor of $6000.0 in Q3 2025.
  • Historically, Interest Expenses has averaged $301411.8 across 5 years, with a median of $186000.0 in 2024.
  • The widest YoY moves for Interest Expenses: up 1064.71% in 2025, down 97.07% in 2025.
  • Tracing SER's Interest Expenses over 5 years: stood at $295000.0 in 2021, then surged by 231.53% to $978000.0 in 2022, then tumbled by 82.0% to $176000.0 in 2023, then tumbled by 90.34% to $17000.0 in 2024, then skyrocketed by 1064.71% to $198000.0 in 2025.
  • Business Quant data shows Interest Expenses for SER at $198000.0 in Q4 2025, $6000.0 in Q3 2025, and $9000.0 in Q2 2025.